<DOC>
	<DOCNO>NCT01005173</DOCNO>
	<brief_summary>This study non-intervention , multicenter study address biomarkers acetaminophen toxicity child . Specifically , study examine acetaminophen ( APAP ) protein adduct marker liver injury blood sample hospitalize child adolescent receive standard dos acetaminophen , child adolescent status post acetaminophen overdose . Ultimately , data generate study use establish second generation biomarkers acetaminophen toxicity , base specific adduct protein , use future risk assessment study child receive acetaminophen .</brief_summary>
	<brief_title>Acetaminophen Biomarkers</brief_title>
	<detailed_description />
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Group A : Children age 118 inclusive Hospitalized child likely receive receive recommend dos APAP Group B : Children age 118 inclusive Children APAP use past 14 day Group C : Children age 118 inclusive Hospitalized acute overdose APAP Time APAP overdose know estimate within two hour window Group A : Acute chronic APAP overdose within 14 day Known history liver disease dysfunction Group B : APAP within last 14 day Known history liver disease dysfunction Group C : Chronic overdoses APAP , define multiple time point ingestion APAP History previous APAP overdose Known preexist liver disease</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Acetaminophen</keyword>
	<keyword>APAP</keyword>
</DOC>